| Indicators | Browse All

Amarin Corporation plc (AMRN)

Healthcare | Drug Manufacturers - General | Dublin, Ireland | NasdaqCM
14.70 USD -0.18 (-1.210%) ⇩ (July 13, 2026, 4 p.m. EDT)
After hours: 14.70

Short-term:★★☆☆☆Long-term:★⯪☆☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 7:02 a.m. EDT

The investment case here is severely compromised by a lack of profitability and a hostile analyst consensus. The company is burning cash with negative operating margins and negative returns on equity, while analysts unanimously recommend selling at a target price significantly below the current trading level. Although the stock recently posted a positive year-over-year gain, this follows six years of cumulative decline, indicating a fragile recovery rather than a turnaround. The balance sheet, while currently liquid, supports a struggling business rather than a fortress. On the short end, options data confirms a bearish sentiment with heavy put buying, suggesting traders expect further weakness. There is no dividend to provide income, and the fundamental metrics paint a picture of a distressed asset rather than a growth opportunity.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL ✓0.037664
AutoARIMA0.038702
AutoETS0.038702
AutoTheta0.057425
MSTL_1150.062778

Forecast horizon: 60 days | Selected: MSTL

Forecast Reliability
Score 34%
H-stat 6.31
Ljung-Box p 0.000
Jarque-Bera p 0.127
Excess Kurtosis -0.13
Attribute Value
Sector Healthcare
Debt to Equity Ratio 1.714
Revenue per Share 10.411
Market Cap 308,245,888
Forward P/E 15.00
Beta 0.80
Profit Margins -15.51%
Website https://www.amarincorp.com

As of July 11, 2026, 7:02 a.m. EDT: Speculators are positioning for a significant downside gap, evidenced by massive open interest in out-of-the-money puts (strikes $11-$14) compared to calls. While there is some speculative volume in far-out calls ($30 strike), the overwhelming capital allocation is in protective puts and deep OTM puts, suggesting a fear of a sharp decline rather than a rally.


Info Dump

Attribute Value
52 Week Change -0.0757764
Address1 One Central Plaza
Address2 8th Floor 36 Dame Street
All Time High 28,500.0
All Time Low 7.0
Ask 14.71
Ask Size 2
Average Analyst Rating 5.0 - Sell
Average Daily Volume10 Day 81,880
Average Daily Volume3 Month 83,162
Average Volume 83,162
Average Volume10Days 81,880
Beta 0.802
Bid 12.64
Bid Size 1
Book Value 21.421
City Dublin
Compensation As Of Epoch Date 1,767,139,200
Country Ireland
Crypto Tradeable 0
Currency USD
Current Price 14.7
Current Ratio 3.485
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 14.97
Day Low 14.6
Debt To Equity 1.714
Display Name Amarin
Earnings Call Timestamp End 1,777,464,000
Earnings Call Timestamp Start 1,777,464,000
Earnings Timestamp 1,777,465,800
Earnings Timestamp End 1,785,328,200
Earnings Timestamp Start 1,785,328,200
Ebitda -2,261,000
Ebitda Margins -0.01043
Enterprise To Ebitda -3.593
Enterprise To Revenue 0.037
Enterprise Value 8,124,902
Eps Forward 0.98
Eps Trailing Twelve Months -1.6
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 14.9628
Fifty Day Average Change -0.26280022
Fifty Day Average Change Percent -0.017563572
Fifty Two Week Change Percent -7.5776396
Fifty Two Week High 20.9
Fifty Two Week High Change -6.2
Fifty Two Week High Change Percent -0.2966507
Fifty Two Week Low 12.96
Fifty Two Week Low Change 1.7399998
Fifty Two Week Low Change Percent 0.13425924
Fifty Two Week Range 12.96 - 20.9
Financial Currency USD
First Trade Date Milliseconds 733,674,600,000
Float Shares 18,530,821
Forward Eps 0.98
Forward P E 14.999999
Free Cashflow 2,224,500
Full Exchange Name NasdaqCM
Full Time Employees 80
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.52365
Gross Profits 113,507,000
Has Pre Post Market Data 1
Held Percent Insiders 0.37877998
Held Percent Institutions 0.22877
Implied Shares Outstanding 20,969,109
Industry Drug Manufacturers - General
Industry Disp Drug Manufacturers - General
Industry Key drug-manufacturers-general
Ir Website http://investor.amarincorp.com/
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,744,329,600
Last Split Factor 1:20
Long Business Summary Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Long Name Amarin Corporation plc
Market us_market
Market Cap 308,245,888
Market State POSTPOST
Max Age 86,400
Message Board Id finmb_407863
Most Recent Quarter 1,774,915,200
Net Income To Common -33,613,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 312,020,339
Number Of Analyst Opinions 1
Open 15.16
Operating Cashflow 25,575,000
Operating Margins -0.1775
Payout Ratio 0.0
Peg Ratio 0.81
Phone 353 0 166 99020
Post Market Change 0.0
Post Market Change Percent 0.0
Post Market Price 14.7
Post Market Time 1,783,973,404
Previous Close 14.88
Price Hint 2
Price To Book 0.68624246
Price To Sales Trailing12 Months 1.4220543
Profit Margins -0.15507
Quick Ratio 2.315
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key sell
Recommendation Mean 5.0
Region US
Regular Market Change -0.18
Regular Market Change Percent -1.20968
Regular Market Day High 14.97
Regular Market Day Low 14.6
Regular Market Day Range 14.6 - 14.97
Regular Market Open 15.16
Regular Market Previous Close 14.88
Regular Market Price 14.7
Regular Market Time 1,783,972,801
Regular Market Volume 83,477
Return On Assets -0.0049900003
Return On Equity -0.07283
Revenue Growth 0.074
Revenue Per Share 10.411
Sand P52 Week Change 0.20847368
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 20,969,109
Shares Percent Shares Out 0.025899999
Shares Short 542,861
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 624,093
Short Name Amarin Corporation plc
Short Percent Of Float 0.026400002
Short Ratio 5.14
Source Interval 15
Symbol AMRN
Target High Price 12.0
Target Low Price 12.0
Target Mean Price 12.0
Target Median Price 12.0
Total Cash 307,822,016
Total Cash Per Share 14.68
Total Debt 7,701,000
Total Revenue 216,760,992
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1.6
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 15.4418
Two Hundred Day Average Change -0.7418003
Two Hundred Day Average Change Percent -0.04803846
Type Disp Equity
Volume 83,477
Website https://www.amarincorp.com
Zip D02 K7K5